Consensus Outset Medical, Inc.

Equities

OM

US6901451079

Market Closed - Nasdaq Other stock markets 01:30:00 30/04/2024 am IST			5-day change	1st Jan Change
2.63 ^USD	+9.58%		+12.39%	-51.39%

17/04	Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S	CI
08/04	BTIG Initiates Outset Medical at Buy Rating With $6 Price Target	MT

Evolution of the average Target Price on Outset Medical, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1e0275358.6DX2Zv9-hE_EIXPQGTpVRUcEmLv-94hlBaQAeqf4A4o.hm_EVq9GyTiqaUC8anUEHQp24ciXsdcKf5JvAu6gduKMRaU8qQzCfoxIKg~c4fe6a382b4a8eda7cbd18de6b46b15e

Analyst Recommendations on Outset Medical, Inc.

BTIG Initiates Outset Medical at Buy Rating With $6 Price Target	08/04	MT
RBC Reduces Price Target on Outset Medical to $5 From $6, Keeps Sector Perform Rating	22/02	MT
RBC Downgrades Outset Medical to Sector Perform From Outperform, Slashes Price Target to $6 From $14	12/01	MT
Morgan Stanley Raises Outset Medical Price Target to $5.50 From $5, Maintains Equal Weight Rating	04/12	MT
Morgan Stanley Cuts Price Target on Outset Medical to $5 From $19, Maintains Equalweight Rating	14/11	MT
TD Cowen Cuts Outset Medical Price Target to $9 From $32, Maintains Outperform Rating	13/23/13	MT
Stifel Cuts Price Target on Outset Medical to $6 From $26, Maintains Buy Rating	13/23/13	MT
BofA Securities Downgrades Outset Medical to Underperform From Buy	13/23/13	MT
Outset Medical Receives Price Target Reduction to $17 From $29 From RBC, Shares Fall Pre-Bell After Revenue Guidance Cut, Outperform Kept	13/23/13	MT
Morgan Stanley Adjusts Price Target on Outset Medical to $19 From $22, Maintains Equalweight Rating	24/23/24	MT
CL King Initiates Outset Medical With Neutral Rating	17/23/17	MT
Morgan Stanley Trims Price Target on Outset Medical to $22 From $23, Maintains Equal-Weight Rating	03/23/03	MT
Morgan Stanley Cuts Price Target on Outset Medical to $23 From $27, Maintains Equalweight Rating	31/23/31	MT
RBC Cuts Price Target on Outset Medical to $29 From $32, Maintains Outperform Rating	04/23/04	MT
RBC Lifts Price Target on Outset Medical to $32 From $31 'to Better Reflect Market Multiples,' Maintains Outperform Rating	14/23/14	MT
Morgan Stanley Adjusts Price Target on Outset Medical to $27 From $17, Maintains Equal-Weight Rating	06/23/06	MT
RBC Initiates Outset Medical at Outperform With $23 Price Target, Says Stock 'Significantly Undervalued' Given Opportunities Ahead	11/22/11	MT
Morgan Stanley Trims Price Target on Outset Medical to $17 From $19, Maintains Equalweight Rating	10/22/10	MT
Goldman Sachs Adjusts Price Target on Outset Medical to $29 From $34, Maintains Buy Rating	09/22/09	MT
Morgan Stanley Adjusts Outset Medical's Price Target to $19 from $22, Retains Equalweight Rating	11/22/11	MT
Goldman Sachs Cuts Outset Medical's Price Target to $34 From $48, Keeps Buy Rating	03/22/03	MT
Morgan Stanley Raises Outset Medical's Price Target to $22 From $20, Maintains Equalweight Rating	02/22/02	MT
Stifel Nicolaus Adjusts Outset Medical's Price Target to $24 From $30, Maintains Buy Rating	18/22/18	MT
Morgan Stanley Lowers Outset Medical to Equalweight From Overweight, Price Target to $20 From $48	14/22/14	MT
Cowen Adjusts Outset Medical's Price Target to $33 From $60, Keeps Outperform Rating	14/22/14	MT